Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: VIR BIOTECHNOLOGY, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2022-09-30 to 2026-01-31
Current total value of award: $74226385.5
Description: VIR BIOTECHNOLOGY - OTA FOR PRE-EXPOSURE PROPHYLACTIC MONOCLONAL ANTIBODIES FOR THE PREVENTION OF INFLUENZA ILLNESS AND MEDICAL COUNTERMEASURES FOR OTHER EMERGING PATHOGENS OF PANDEMIC POTENTIAL